HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.

Abstract
The absence of mutations in the IgV genes, together with the presence of ZAP-70 and CD38, are the most reliable negative prognostic markers for chronic lymphocytic leukemia (CLL) patients. Several lines of evidence indicate that CD38 may be not only a diagnostic marker but also a key element in the pathogenetic network in CLL. First, CD38 is a receptor that induces proliferation and increases survival of CLL cells. Second, CD38 signals start upon interaction with the CD31 ligand expressed by stromal and nurse-like cells. Third, CD38/CD31 contacts up-regulate CD100, a semaphorin involved in sustaining CLL growth. Fourth, evidence that nurselike cells express high levels of CD31 and plexin-B1, the high-affinity ligand for CD100, offers indirect confirmation for this model of receptor cross-talk. Elements of variation in the clinical course of CD38(+) CLL patients include (1) potential intersection with ZAP-70, a kinase involved in the CD38 signaling pathway in T and natural killer (NK) cells, and (2) the effects of genetic polymorphisms of the receptors involved, at least of CD38 and CD31. Consequently, CD38 together with ZAP-70 appear to be the key elements of a coreceptor pathway that may sustain the signals mediated by the B-cell receptor and potentially by chemokines and their receptors. This would result in acquisition of increased survival potential, providing clues to the poorer prognosis of CD38(+) patients.
AuthorsSilvia Deaglio, Tiziana Vaisitti, Semra Aydin, Enza Ferrero, Fabio Malavasi
JournalBlood (Blood) Vol. 108 Issue 4 Pg. 1135-44 (Aug 15 2006) ISSN: 0006-4971 [Print] United States
PMID16621959 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antigens, CD
  • Biomarkers, Tumor
  • CD100 antigen
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Receptors, Chemokine
  • Semaphorins
  • ZAP-70 Protein-Tyrosine Kinase
  • ADP-ribosyl Cyclase 1
Topics
  • ADP-ribosyl Cyclase 1 (genetics, metabolism)
  • Antigens, CD (metabolism)
  • B-Lymphocytes (metabolism, pathology)
  • Biomarkers, Tumor (genetics, metabolism)
  • Cell Proliferation
  • Disease-Free Survival
  • Humans
  • Killer Cells, Natural (metabolism, pathology)
  • Leukemia, Lymphocytic, Chronic, B-Cell (genetics, metabolism, pathology)
  • Platelet Endothelial Cell Adhesion Molecule-1 (metabolism)
  • Polymorphism, Genetic
  • Receptors, Chemokine (metabolism)
  • Semaphorins (metabolism)
  • Signal Transduction (genetics)
  • Stromal Cells (metabolism, pathology)
  • T-Lymphocytes (metabolism, pathology)
  • ZAP-70 Protein-Tyrosine Kinase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: